← Back to Search

Stress Management Program for Heart Attack

N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up about 10 weeks
Awards & highlights

Study Summary

This trial will use PET/CT scans to study how stress affects the inflammation of arteries and the activation of the amygdala.

Eligible Conditions
  • Heart Attack
  • Cardiovascular Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~about 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and about 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in amygdala activation

Trial Design

1Treatment groups
Experimental Treatment
Group I: SMART ProgramExperimental Treatment1 Intervention
The Stress Management and Resiliency Training (SMART) Program is a multimodal mind-body and cognitive skills-based program that teaches participants a variety of different approaches for reducing their physiologic stress response. The program is delivered virtually (online) for 1.5 hours once a week for 8 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stress Management and Resiliency Training Program
2022
N/A
~10

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
914 Previous Clinical Trials
4,720,705 Total Patients Enrolled

Media Library

Stress Management and Resiliency Training Program Clinical Trial Eligibility Overview. Trial Name: NCT05415735 — N/A
Heart Attack Research Study Groups: SMART Program
Heart Attack Clinical Trial 2023: Stress Management and Resiliency Training Program Highlights & Side Effects. Trial Name: NCT05415735 — N/A
Stress Management and Resiliency Training Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05415735 — N/A
~3 spots leftby May 2025